Ascentage Pharma Group International (AAPG): Narx/daromad koeffitsiyenti
Ascentage Pharma Group (AAPG) istiqbollari olverembatinibning xalqaro tan olinishiga va AQSh bozoriga kengayishiga bog'liq. Tarixiy P/S dinamikasi bozor kutuvlarini tasdiqlaydi, bunda joriy parametr 8.50 ga tengdir. O'sish maqsadli dori vositalarining global targ'iboti va yirik sog'liqni saqlash gigantlari bilan ittifoqlarga asoslangan. Ijobiy prognoz innovatsion R&D doirasida o'simliklarning qarshilik ko'rsatishiga qarshi kuratishga qaratilgan apoptoz ingibitorlarining ishlab chiqilishi bilan qo'llab-quvvatlanadi.
Ascentage (AAPG) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- kompaniyaning balans qiymati tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Ascentage Pharma Group|AAPG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Ascentage Pharma Corp|AAPG - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Ascentage|AAPG - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Ascentage Pharma|Shoshilinch likvidlik ascentage.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AAPG - Sof daromad|Kutilayotgan sof daromad Ascentage Pharma Group|AAPG - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati Ascentage Pharma Group International|AAPG - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Ascentage|AAPG - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Ascentage Pharma|AAPG - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi ascentage.com|AAPG - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Ascentage Pharma Group
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:AAPG ascentage.com
Fundamental barqarorlikni bozor shovqinlaridan ajratish uchun bozor kapitalizatsiyasining yillik savdolarga nisbati ishlatiladi, bu esa hisob-kitobdagi buzilishlarsiz daromadning har bir birligini baholash imkonini beradi. Sotuvlar nisbatidagi narx koeffitsiyentini tahlil qilish investorlarning joriy kutganlarini olverembatinibning tijorchashtirish salohiyati va Ascentage Pharma Pharma Group (AAPG) kompaniyasining AQSh bozoriga kengayish istiqbollari bilan muvofiqlashtirishga yordam beradi.
Raqobatdosh kompaniyalar
P/S multiplikatori beigene.com (ONC)|Narxning daromadga nisbati Halozyme HALO|Narx/daromad koeffitsiyenti Revolution Medicines Inc (RVMD)|CG Oncology Corp - P/S multiplikatori|UroGen Pharma Corp (URGN) - Kapitalizatsiyaning daromadga nisbati|BCAX: P/S multiplikatori|Sotuvga nisbatan narx personalis.com (PSNL)|Narxning daromadga nisbati Erasca|Kapitalizatsiya va daromad nisbati DCTH (Delcath Systems Inc)|Kapitalizatsiyaning daromadga nisbati YMAB (YmAbs)|Kapitalizatsiyaning sotish hajmiga nisbati AURA|P/S multiplikatori CADL (Candel Therapeutics, Inc.)|P/S multiplikatori accuray.com ARAY|SELLAS Life Sciences Group Inc. - P/S multiplikatori|Narx/daromad multiplikatori Actuate Therapeutics Inc. (ACTU)|CTOR: P/S multiplikatori|Sotuvga nisbatan narx TuHURA Biosciences (HURA)|Kapitalizatsiyaning daromadga nisbati TARA|FATE: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Aadi Bioscience Inc (WHWK)|TCRX: Narxning sotuvga nisbati|P/S multiplikatori CSBR (Champions Oncology, Inc.)|Bozor kapitallashuvining daromadga nisbati XBIT|CEL-SCI Corp - P/S multiplikatori|OSTX - P/S multiplikatori|Radiopharm Theranostics (RADX) - Narxning daromadga nisbati|Artiva Biotherapeutics - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Adlai Nortye Ltd|Kapitalizatsiyaning daromadga nisbati Veru Corporation (VERU)|P/S multiplikatori TPST|P/S multiplikatori xiliotx.com (XLO)|Renovaro - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati MURA|Kairos Pharma Inc - P/S multiplikatori|Narx/daromad multiplikatori OnKure Therapeutics Inc (OKUR)|w2.cytomed.sg (GDTC) - Narxning daromadga nisbati|Curis - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Apollomics Inc.|Sotuvga nisbatan narx Tharimmune Inc THAR|Kapitalizatsiyaning daromadga nisbati ADVB (Advanced Biomed Inc)|P/S multiplikatori Genprex Inc (GNPX)|Narxning daromadga nisbati Calidi Biotherapeutics, Inc. CLDI|SBFM (sunshinebiopharma.com) - Narxning sotuvga nisbati|Xenetic Bio - P/S multiplikatori|SLRX - P/S multiplikatori|PPBT: P/S multiplikatori|American Oncology Network, Inc. (AONC) - P/S multiplikatori|Narxning daromadga nisbati BeiGene, Ltd.|checkpointtx.com - Narxning sotuvga nisbati|P/S multiplikatori ELEV|icadmed.com (ICAD) - Narx/daromad multiplikatori|P/S multiplikatori IKNA (Ikena Oncology)|NTBL - Kapitalizatsiyaning daromadga nisbati|Viracta - P/S multiplikatori|MOR - P/S multiplikatori|NAYA Biosciences Inc. (NAYA) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati AAPGV
